AstraZeneca (AZ) decided to team up with Moderna, a rival Covid-19 vaccine maker, to develop a new treatment for heart failure.AZ’s investigational drug with Moderna’s mRNA technology, which can be injected directly into a patient’s heart, showed a potential to treat heart failure by restoring damag
SK said it plans to sign an exclusive contract by this year-end to invest in The Center for Breakthrough Medicines (CBM), a Philadelphia-based contract development and manufacturing organization (CDMO) specializing in gene and cell therapies.SK expects to emerge as a leading gene and cell therapy CM
Seegene said it has set up Seegene Colombia S.A.S. in Bogota, Colombia, to speed its advance to the Latin American market.It is Seegene’s eighth foreign branch, following those in the U.S., Germany, Italy, the Middle East, Brazil, Canada, and Mexico.Colombia has the third-largest population of 50 mi
SK Bioscience said it has submitted a product approval application to the Ministry of Food and Drug Safety for NVX-CoV2373, a Covid-19 vaccine developed by Novavax.The approval of NVX-CoV2373, administered in 0.5-ml dose to the muscle twice at 21-day intervals, will undergo a review by an expert adv
Pharma Research Bio, which plans to fight the Ministry of Food and Drug Safety’s decision to revoke the license of its botulinum toxin ReNTox, released materials to the media that were slightly different from the truth, industry sources said.The company used vague expressions in the materials regard
Chong Kun Dang said its Indonesian joint venture CKD OTTO signed an export agreement worth $32 million with Saidal, the largest state-run pharmaceutical company in Algeria.Under the accord, CKD OTTO will ship anticancer injections produced at its Indonesian plant to Algeria for the next five years u
Korean pharmaceutical companies are using metaverse, a convergence of virtual and physical space, to actively communicate with newcomers of the “MZ generation.”MZ generation, or millennials and Generation Z, refers to people born between 1980 and 1994 (millennials) and between 1995 and 2004 (Generat
Following Medytox, Hugel and Pharma Research Bio have encountered a crisis, as the government is revoking their manufacturing licenses of botulinum toxin (BTX) products for violating certification and shipping regulations, industry insiders said Friday.A fierce legal battle is going on over whether
Celltrion said that the European Medicines Agency’s (EMA) Committee for Human Medical Products (CHMP) issued a positive scientific opinion on Regkirona, a Covid-19 treatment.According to Celltrion, Regkirona and Roche’s Ronapreve are the first monoclonal antibody medicines to receive a positive opin
A Seoul court allowed Hugel to continue selling botulinum toxin Botulax temporarily, even though the Ministry of Food and Drug Safety earlier said it would order the company to suspend making and selling the product due to failure to obtain state approval for domestic sales.With the quick court’s de
A real-world study has confirmed the safety and efficacy of Novartis’ gene therapy Zolgensma (ingredient: onasemnogene abeparvovec) in treating pediatric patients with spinal muscular atrophy (SMA) weighing up to 15 kilograms.The study demonstrated the safety and efficacy of Zolgensma in pediatric S
Hanmi Pharmaceutical said Thursday that its foreign partners are facilitating the global commercialization of the company’s anticancer drug candidates, such as HM43239, belvarafenib, and poziotinib.Aptose Bioscience, Roche and its subsidiary Genentech, and Spectrum Pharmaceuticals are speeding up th
Civic groups accused Pfizer of abusing power against governments over Covid-19 vaccine negotiations around the world.The Korean government should disclose the vaccine purchase agreement signed with Pfizer, and the company should stop monopolistic sales of the Covid-19 vaccine and waive vaccine paten
Genexine said that the Ministry of Food and Drug Safety has approved its investigational new drug (IND) application for conducting a phase 2 clinical trial using its GX-I7 and Roche's Avastin to treat recurrent glioblastoma multiforme (rGBM).With the approval, the company aims to evaluate the effica
A revocation of the license of Pharma Research Bio’s botulinum toxin (BTX) ReNTox is expected to deal a blow to LG Chem, Pharma Research Bio’s partner company in the Chinese market.On Wednesday, the Ministry of Food and Drug Safety (MFDS) said Pharma Research Bio violated the Pharmaceutical Affairs
Korea Research-based Pharma Industry Association (KRPIA) expressed concerns over the Health Insurance Review Assessment Service’s (HIRA) plan of evaluating a drug’s cost-effectiveness at 80 percent of the lowest drug price in Advanced 7 (A7) countries.The HIRA’s plan was revealed when it replied to
Pharos iBio said its PHI-501, a next-generation anticancer drug for acute myeloid leukemia (AML), has won orphan drug designation from the U.S. Food and Drug Administration (FDA).It was the U.S. regulator’s second orphan drug designation of the Korean company’s product. FDA granted similar status to
Hemophilia patients often call Sanofi’s fitusiran “a dream treatment” because the single subcutaneous injection once a month shows a preventive effect.The investigational drug proved its prophylaxis effect in patients with hemophilia A or B with inhibitors in a recent study, drawing much attention.H
Merck said it has signed a memorandum of understanding (MoU) with GI Innovation, a Korean bioventure company, to further R&D efforts on critical life-saving cancer treatments and drugs for allergy-related conditions.Under the accord, Merck will support GI Innovation with technologies and services, i
GemVax & KAEL said its study results of GV1001 showing an inhibitory effect on prostate cancer cell metastasis was published in the international journal, Cell & Bioscience.The company research team found the possibility that its Alzheimer’s drug candidate GV1001 could be a GnRHR ligand that inhibit